Axt Inc (AXTI) · Oct 28, 2026 · Share issuance
$285M-$545M Tongmei financing — minimum ~$285M; maximum ~$545M; AXT retains ~73.40% at maximum
AXT announced a Tongmei financing of up to $545 million to expand indium phosphide capacity, while closing, IPO timing and redemption obligations remain unresolved.
AXT is in a rapid InP capacity buildout, driven by surging optical-connectivity and AI data-center demand: second-quarter InP revenue reached a company high, while recent customer agreements have reserved additional capacity. This filing adds a substantial new funding source for that expansion. Institutional investors have committed to invest at least approximately $285 million and potentially $545 million into Tongmei, while AXT separately agreed to inject the RMB equivalent of $400 million. The proceeds are earmarked for InP manufacturing expansion, broader operations, capital spending and working capital.
| Filing item | Amount / term |
|---|---|
| Investor financing — minimum | Approximately $285M (financing terms) |
| Investor financing — maximum | Approximately $545M (financing terms) |
| AXT recapitalization of Tongmei | Approximately $400M (financing terms) |
| AXT ownership after maximum investment | Approximately 73.40% (financing terms) |
| Investor information-rights threshold | More than 4.5% collectively (Investor Rights) |
| Redemption return | 8% annual rate, compounded (Redemption Rights) |
| Qualified IPO return hurdle | 13% annual internal rate of return (Redemption Rights) |
The financing strengthens the operating story, but it is not yet cash in the business. Closing depends on government filings and other customary conditions, is only expected in December 2026, and the investors are not obligated to fund the maximum amount. The minimum closing can terminate if it has not occurred by December 20, 2026. 〔0〕 〔1〕
The deal also formalizes a path toward a Hong Kong IPO while adding a financing overhang. Investors receive one of nine board seats, protective consent rights, liquidation and distribution priority, and redemption rights if Tongmei has not completed a qualifying IPO within three years of closing. That is materially better than relying solely on AXT’s balance sheet to fund expansion, but the redemption mechanics could turn the financing into a future cash obligation if the listing path slips. This matters because Tongmei had already abandoned its long-pending Shanghai STAR Market application and redirected efforts toward Hong Kong, making the listing objective known before this filing.
AXT preserves control, but minority economics will increase. Assuming the maximum investment, AXT expects to retain approximately 73.40% ownership and continue consolidating Tongmei, so the financing does not currently separate the subsidiary from AXT’s financial statements. However, new investors gain priority rights and the eventual IPO or sale would share more of Tongmei’s value with outside holders. 〔2〕
Bottom line: This is a meaningful funding step for AXT’s capacity-constrained InP business and makes the Hong Kong listing strategy more credible, but the benefit is conditional until the December closing and remains tied to a demanding IPO timetable and redemption rights.
December 2026 financing closing
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!